This article was subjected to a comprehensive fact-checking process. Our professional fact-checkers verify article information against primary sources, reputable publishers, and experts in the field.

1 seed Emma Navarro won her second career title with a 6-0, 6-0 victory over qualifier Emiliana Arango at the Merida Open Akron on Sunday. Navarro is just the fifth woman this century to win a WTA ...

May rats continue to squeak like rats, may birds chirp like birds, may humans speak like humans, may the king’s horsetail gradually diminish to a needle, owing to many years of use. Ikú Bàbá ...

Make your plans and mark your calendar; in just over a week, you can visit any of America's iconic National Parks free of charge. On Sunday, April 19, all of America's 63 National Parks will be free ...

Rebecca Sramkova advanced to her first quarterfinal of the season after defeating Brazil's Beatriz Haddad Maia in straight sets in the Round of 16 at the Merida Open Akron. Why not watch this next… ...

Credit: Dalin Ou via Getty Images. US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing antibodies in autoimmune diseases and ...

Global pharmaceutical stocks plunged on the news Wednesday, with U.K.-based AstraZeneca dropping 5% and Swiss drugmaker Novartis losing 3% in early trading on U.S. exchanges. Top U.S. drugmakers, ...

Merida Biosciences, a startup formed by venture capital firm Third Rock Ventures, emerged from stealth Tuesday, revealing $121 million in financing and a lead program for a common autoimmune ...

Merida Therapeutics was seeded by Third Rock back in 2022, when the biotech’s co-founder and chief scientific officer Dario Gutierrez, Ph.D., was entrepreneur-in-residence at the VC firm.

Series A financing co-led by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures Merida Biosciences, a biotechnology company pioneering a new class of precision therapeutics designed ...

April 08, 2025--(BUSINESS WIRE)--Merida Biosciences, a biotechnology company pioneering a new class of precision therapeutics designed to selectively and durably eliminate the pathogenic antibody ...

The stalactites and stalagmites of Sequoia National Park’s Crystal Cave, a sprawling subterranean wonder that’s been closed for four years, will be accessible again this summer. But to get in ...